Caligan Partners LP

Caligan Partners LP reported 26 holdings worth US$1.63B as of Sep 30, 2026 (Form 13F)

As of Sep 30, 2026 · Filed Nov 16, 2026

Caligan Partners LP reported 26 holdings worth US$1.63B as of Sep 30, 2026. Largest: Revolution Medicines, Inc., Liquidia Corporation and Abivax SA. Filed Nov 16, 2026 (Form 13F).

Holdings
26
Value as reported
US$1.63B

The filing in full

CompanySharesValue as reported% of portfolio
Revolution Medicines, Inc.1.96MUS$403M24.6%
Liquidia Corporation8.12MUS$246M15.0%
Abivax SA1.56MUS$154M9.4%
Vaxcyte, Inc.2.19MUS$125M7.6%
Exelixis, Inc.1.55MUS$90.7M5.6%
Tango Therapeutics, Inc.2.5MUS$62.4M3.8%
ADMA Biologics Inc5.88MUS$58.9M3.6%
Immunocore Holdings plc1.67MUS$50.6M3.1%
Avalo Therapeutics, Inc.3.27MUS$50.1M3.1%
LB Pharmaceuticals Inc1.51MUS$49.6M3.0%
Viridian Therapeutics, Inc.2.19MUS$45.2M2.8%
Vor Biopharma Inc.1.93MUS$36.7M2.2%
Inventiva SA9.19MUS$33.9M2.1%
Opus Genetics, Inc.5.96MUS$28.9M1.8%
Aura Biosciences, Inc.4.59MUS$28.8M1.8%
Anika Therapeutics Inc.1.44MUS$28.2M1.7%
SAB Biotherapeutics, Inc.8.74MUS$27.7M1.7%
Sagimet Biosciences Inc. - Series A2.79MUS$27.6M1.7%
Sensei Biotherapeutics, Inc.890KUS$26.5M1.6%
Tyra Biosciences, Inc.911KUS$19.9M1.2%
Obsidian Therapeutics, Inc.886KUS$12.2M0.74%
Eupraxia Pharmaceuticals, Inc.1.16MUS$10.6M0.65%
Artiva Biotherapeutics, Inc.1.48MUS$10.5M0.65%
Verrica Pharmaceuticals Inc.924KUS$4.43M0.27%
TCGX Acquisition Corp.200KUS$2.5M0.15%
Cellectar Biosciences, Inc.470KUS$865K0.05%
MBX Biosciences, Inc.0US$00.00%
Xenon Pharmaceuticals Inc.0US$00.00%

Source

Download original · View original at SEC

Related